Today, along with Apheris, we're introducing the Antibody Developability Consortium, with AbbVie…
Ginkgo Bioworks
Visit on X@Ginkgo40K followers
22,752 views
Today, along with Apheris, we're introducing the Antibody Developability Consortium, with AbbVie, argenx, LundbeckUS, and Takeda as founding members.
The Consortium helps pharmaceutical and biotech companies predict manufacturability and developability risks earlier by building the field’s largest standardized antibody developability dataset.
Read the full press release here:
1 Comment
Comments from the original post on X (Twitter)

@RoehmRobin
@apheris_AI @abbvie @argenxglobal @LundbeckUS @TakedaPharma Thanks for the great collaboration!
